Memphasys Tech: Trial Results Prove It Lifts the Guys' Game in IVF

The Market HeraldMar 23 19:07 ET

Memphasys Ltd: Half Yearly Report and Accounts

ASXFeb 28 01:40 ET · Announcements

Memphasys Ltd Targets Global Expansion in Fertility and Diagnostics

TipRanksFeb 25 02:23 ET

Memphasys Completes Felix System Clinical Trial, Shares Rise Past 14%

MT NewswiresFeb 11 02:00 ET

Memphasys Says Publication of Study Demonstrates Oxidative Stress Profiling System Potential

MT NewswiresJan 15 21:44 ET

Memphasys to Start Utilization Testing of Reproductive Biotechnology Product in China

MT NewswiresJan 5 20:07 ET

Memphasys Ltd to Quote New Shares on ASX

TipRanksDec 20, 2024 01:47 ET

Memphasys Ltd Announces Director Resignation

TipRanksNov 26, 2024 23:09 ET

Memphasys Ltd Issues New Unquoted Loan Options

TipRanksNov 8, 2024 01:20 ET

Memphasys Ltd Unveils Product Development Timelines

TipRanksOct 24, 2024 23:00 ET

Memphasys Ltd Eyes European Market With New Strategies

TipRanksOct 24, 2024 02:38 ET

Memphasys Ltd Nears Completion of Felix System Trial

TipRanksOct 23, 2024 21:59 ET

ASX Small-Cap Stocks to Watch

MT NewswiresOct 17, 2024 19:59 ET

Memphasys Ltd Issues Supplementary Prospectus

TipRanksOct 8, 2024 04:37 ET

Memphasys Ltd Shareholders to Vote on Share Issuance

TipRanksSep 24, 2024 18:39 ET

Memphasys Ltd: Annual Financial Report for the year ended 30 June 2024

Sep 18, 2024 01:36 ET · Announcements

Memphasys Launches AU$2 Million Capital Raise for Japanese Clinical Trial

MT NewswiresSep 12, 2024 00:25 ET

Memphasys Ltd Announces Voluntary Trading Suspension

TipRanksSep 10, 2024 20:57 ET

Memphasys Ltd Addresses Cleansing Notice Issue

TipRanksSep 7, 2024 14:56 ET

Memphasys Ltd Advances Equine Fertility Technology

TipRanksSep 3, 2024 18:38 ET